Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98


Commentary on local therapy in men who present with a metastatic prostate cancer from special issue senior guest editor.

Kim IY.

Am J Clin Exp Urol. 2019 Apr 25;7(2):61-63. eCollection 2019. No abstract available.


12th World Congress on Neurohypophysial Hormones Mangaratiba, Rio de Janeiro, Brazil - July 26th-29th, 2017.

Sladek C, Rocha MJA, Ludwig M.

J Neuroendocrinol. 2018 Jul 28:e12636. doi: 10.1111/jne.12636. [Epub ahead of print]


Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital.

Patel DN, Jha S, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Chapin BF, Freedland SJ.

Int J Urol. 2018 Dec;25(12):998-1004. doi: 10.1111/iju.13806. Epub 2018 Sep 25.


Editor profile: Guest editor of special issue "Bile Acids and Nuclear Receptors in Digestive System and Therapy".

[No authors listed]

Acta Pharm Sin B. 2015 Mar;5(2):91-2. doi: 10.1016/j.apsb.2015.03.004. Epub 2015 Mar 25. No abstract available.


Management of metastatic prostate cancer: the crucial role of geriatric assessment.

Droz JP, Chaladaj A.

BJU Int. 2008 Mar;101 Suppl 2:23-9. doi: 10.1111/j.1464-410X.2007.07486.x. Review.


Letter from the New Editor-in-Chief.

Rampelotto PH.

Life (Basel). 2014 Jan 8;4(1):1-3. doi: 10.3390/life4010001.


Nine-year prostate cancer survival differences between aggressive versus conservative therapy in men with advanced and metastatic prostate cancer.

Dall'Era MA, Lo MJ, Chen J, Cress R, Hamilton AS.

Cancer. 2018 May 1;124(9):1921-1928. doi: 10.1002/cncr.31285. Epub 2018 Mar 2.


Cancer Letters special issue hepatobiliary cancer featuring the guest editor.

Wang H.

Cancer Lett. 2016 Sep 1;379(2):163. doi: 10.1016/j.canlet.2016.01.029. Epub 2016 Jan 28. No abstract available.


Editor Profile: Guest Editor of Special Issue on Biomimetic Nanoparticles for Drug Delivery.

[No authors listed]

Acta Pharm Sin B. 2018 Jan;8(1):1. doi: 10.1016/j.apsb.2018.01.002. Epub 2018 Feb 3. No abstract available.


Editor Profile: Guest Editor of Special Issue on Targets and Anticancer Drug Research.

Fu L.

Acta Pharm Sin B. 2017 Jan;7(1):1. doi: 10.1016/j.apsb.2016.12.005. Epub 2017 Jan 14. No abstract available.


Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.

Zagars GK, Pollack A, von Eschenbach AC.

Int J Radiat Oncol Biol Phys. 1995 Aug 30;33(1):23-35.


Editor Profile: Guest editor of special issue "Research Progress of Anti-infective Drugs".

Jiang JD.

Acta Pharm Sin B. 2014 Aug;4(4):239. doi: 10.1016/j.apsb.2014.07.003. Epub 2014 Aug 26. No abstract available.


Editor profile: Guest editor of special issue "Drug Delivery System and Pharmaceutical Technology".

Wu C.

Acta Pharm Sin B. 2014 Feb;4(1):1. doi: 10.1016/j.apsb.2014.01.004. Epub 2014 Feb 22. No abstract available.


From the Guest Editor: The Spectrum of Treatment of Metastatic Prostate Cancer: Present and Future.

Petrylak DP.

Cancer J. 2016 Sep/Oct;22(5):321. No abstract available.


Editor Profile: Guest Editors of the Special Issue "Functional Materials, Nanocarriers, and Formulations for Targeted Therapy".

Gao Z, Kang HC.

Acta Pharm Sin B. 2016 Jul;6(4):259. doi: 10.1016/j.apsb.2016.06.007. Epub 2016 Jul 15. No abstract available.


A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.

Klein EA, Yousefi K, Haddad Z, Choeurng V, Buerki C, Stephenson AJ, Li J, Kattan MW, Magi-Galluzzi C, Davicioni E.

Eur Urol. 2015 Apr;67(4):778-86. doi: 10.1016/j.eururo.2014.10.036. Epub 2014 Nov 12.


Local treatment for metastatic prostate cancer: A systematic review.

Tilki D, Pompe RS, Bandini M, Marchioni M, Kretschmer A, Tian Z, Karakiewicz PI, Evans CP.

Int J Urol. 2018 May;25(5):390-403. doi: 10.1111/iju.13535. Epub 2018 Mar 23.


Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.

Satkunasivam R, Kim AE, Desai M, Nguyen MM, Quinn DI, Ballas L, Lewinger JP, Stern MC, Hamilton AS, Aron M, Gill IS.

J Urol. 2015 Aug;194(2):378-85. doi: 10.1016/j.juro.2015.02.084. Epub 2015 Feb 21.

Supplemental Content

Support Center